Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259571 | 12525957 | 1 | I | 20160413 | 20160705 | 20160705 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-029916 | BRISTOL MYERS SQUIBB | 43.00 | YR | F | Y | 0.00000 | 20160705 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259571 | 12525957 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 21436 | TABLET | ||||||||||
| 125259571 | 12525957 | 2 | C | CONGESCOR | BISOPROLOL | 1 | Unknown | 2.5 MG, UNK | U | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125259571 | 12525957 | 1 | Psychotic disorder |
| 125259571 | 12525957 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125259571 | 12525957 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125259571 | 12525957 | Bulimia nervosa | |
| 125259571 | 12525957 | Hunger | |
| 125259571 | 12525957 | Increased appetite | |
| 125259571 | 12525957 | Product use issue | |
| 125259571 | 12525957 | Treatment noncompliance | |
| 125259571 | 12525957 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |